Caplin Point Laboratories Limited (NSE: CAPLIPOINT)
India flag India · Delayed Price · Currency is INR
2,397.15
-20.50 (-0.85%)
Dec 24, 2024, 3:29 PM IST

Caplin Point Laboratories Company Description

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.

The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion.

It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals.

Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Caplin Point Laboratories Limited
Country India
Founded 1990
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 3,406
CEO Sridhar Ganesan

Contact Details

Address:
Ashvich Tower
Chennai, 600096
India
Phone 91 44 2496 8000
Website caplinpoint.net

Stock Details

Ticker Symbol CAPLIPOINT
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE475E01026
SIC Code 2834

Key Executives

Name Position
Dr. Sridhar Ganesan MD and Whole Time Director
D. Muralidharan Chief Financial Officer
Partheeban Vivek Siddarth Chief Operating officer
G. Venkatram General Counsel, Company Secretary and Compliance Officer
M. Sathya Narayanan Deputy Chief Financial Officer
Ashok Gorekey Partheeban Head of Marketing - Latam Business
Thiagaraja Manikandan Chief Transformation and Digital Officer